Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release.

Decorin (DCN) is a ubiquitous proteoglycan comprised of a core protein attached to a single dermatan/chondroitin sulphate glycosaminoglycan chain. It may play a role in regulation of collagen fibrillogenesis and function as a reservoir of transforming growth factor beta (TGF-beta) in the extracellular milieu. We have examined the susceptibility of DCN to five different matrix metalloproteinases (MMPs): MMP-1 (tissue collagenase), MMP-2 (gelatinase A), MMP-3 (stromelysin 1), MMP-7 (matrilysin) and MMP-9 (gelatinase B). MMP-2 and MMP-3 digest DCN into seven major fragments in a similar pattern. The N-terminal sequence of the two fragments generated by MMP-2 and MMP-3 is Leu211-Lys-Gly-Leu-Asn, but that of the others is Asp1-Glu-Ala-Ser-Gly. MMP-7 cleaves DCN into three major fragments which have the N-termini Asp1-Glu-Ala-Ser-Gly, Glu2-Ala-Ser-Gly-Ile and Leu244-His-Leu-Asp-Asn. Activities of MMP-1 and MMP-9 against DCN are negligible. The values of Km for the MMPs capable of degrading DCN are very similar (10-12 microM), but the kcat/Km value for MMP-7 (30.5 microM-1.h-1) is 4.5-fold higher than those for MMP-2 and MMP-3. Incubation of a DCN-TGF-beta1 complex with MMP-2, -3 or -7 results in release of TGF-beta1 from the complex. These data indicate proteolytic degradation of DCN by MMP-2, MMP-3 and MMP-7, and suggest the possibility that, under pathophysiological conditions, the digestion by the MMPs may induce tissue reactions mediated by TGF-beta1 released from DCN in the connective tissues.

[1]  Y. Okada,et al.  A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[2]  Hiroshi Sato,et al.  Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.

[3]  Oldberg,et al.  Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.

[4]  H Shikata,et al.  Degradation of vitronectin by matrix metalloproteinases‐1, ‐2, ‐3, ‐7 and ‐9 , 1995, FEBS letters.

[5]  B. Hinzmann,et al.  cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. , 1995, European journal of biochemistry.

[6]  P. Roughley,et al.  Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. , 1995, Arthritis and rheumatism.

[7]  E. Schönherr,et al.  Decorin-Type I Collagen Interaction , 1995, The Journal of Biological Chemistry.

[8]  K. Imai,et al.  Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells , 1995, The Journal of Biological Chemistry.

[9]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[10]  L. Siracusa,et al.  The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. , 1994, The Journal of biological chemistry.

[11]  E. Schönherr,et al.  Selective inactivity of TGF‐β/decorin complexes , 1994 .

[12]  Y. Okada,et al.  Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases , 1994, FEBS letters.

[13]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[14]  E. Schönherr,et al.  Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans. , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[15]  D. Lovett,et al.  Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. , 1994, The American journal of pathology.

[16]  E. Ruoslahti,et al.  Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. , 1993, The Journal of biological chemistry.

[17]  P. Roughley,et al.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.

[18]  B. Johnstone,et al.  Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. , 1993, The Biochemical journal.

[19]  R. Mecham,et al.  Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. , 1993, The Journal of biological chemistry.

[20]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[21]  K. Naka,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.

[22]  R. Miehlke,et al.  Presence of small proteoglycan fragments in normal and arthritic human cartilage. , 1992, Arthritis and rheumatism.

[23]  M. Cockett,et al.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). , 1991, The Biochemical journal.

[24]  L. Sandell,et al.  Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procore protein. , 1991, The Journal of biological chemistry.

[25]  A Yasui,et al.  Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.

[26]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[27]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[28]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[29]  H. Kresse,et al.  Extracellular accumulation of small dermatan sulphate proteoglycan II by interference with the secretion-recapture pathway. , 1990, The Biochemical journal.

[30]  H. Kresse,et al.  Endocytosis of a small dermatan sulphate proteoglycan. Identification of binding proteins. , 1989, The Biochemical journal.

[31]  E. Ruoslahti,et al.  Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation , 1988, Nature.

[32]  Y. Okada,et al.  The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. , 1988, The Biochemical journal.

[33]  T. Koob,et al.  Characterization and interactions of a fragment of the core protein of the small proteoglycan (PGII) from bovine tendon. , 1987, Biochemical and biophysical research communications.

[34]  E. Ruoslahti,et al.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Poole,et al.  Biological roles of dermatan sulphate proteoglycans. , 1986, Ciba Foundation symposium.

[36]  L. Tang,et al.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.

[37]  J. D. Gregory,et al.  Proteodermatan sulfate isolated from pig skin. , 1982, The Journal of biological chemistry.

[38]  A. Eisen,et al.  The collagen substrate specificity of human skin fibroblast collagenase. , 1981, The Journal of biological chemistry.

[39]  D. Heinegård,et al.  A novel low-molecular weight chondroitin sulphate proteoglycan isolated from cartilage. , 1981, The Biochemical journal.